CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

Autor: Gleeson, M., Peckitt, C., To, Y.M., Edwards, L., Oates, J., Wotherspoon, A., Attygalle, A.D., Zerizer, I., Sharma, B., Chua, S., Begum, R., Chau, I., Johnson, P., Ardeshna, K.M., Hawkes, E.A., Macheta, M.P., Collins, G.P., Radford, J., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., Cunningham, D.

Publikováno v: The Lancet. Haematology
Gleeson, M, Peckitt, C, To, Y M, Edwards, L, Oates, J, Wotherspoon, A, Attygalle, A D, Zerizer, I, Sharma, B, Chua, S, Begum, R, Chau, I, Johnson, P, Ardeshna, K M, Hawkes, E A, Macheta, M P, Collins, G P, Radford, J, Forbes, A, Hart, A, Montoto, S, McKay, P, Benstead, K, Morley, N, Kalakonda, N, Hasan, Y, Turner, D & Cunningham, D 2018, ' CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T) : a phase 2, multicentre, randomised, open-label trial ', The Lancet Haematology, vol. 5, no. 5, pp. e190-e200 . https://doi.org/10.1016/S2352-3026(18)30039-5

Background: Outcomes with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) or CHOP-like chemotherapy in peripheral T-cell lymphoma are poor. We investigated whether the regimen of gemcitabine, cisplatin, and methylprednisolone (GEM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ea60a55fd4ff17cfaee554c8fe51311a
https://eprints.soton.ac.uk/420538/

The role of early F-FDG PET/CT in prediction of progression-free survival after Y radioembolization: comparison with RECIST and tumour density criteria.

Autor: Zerizer, I.¹ imene@doctors.org.uk, Al-Nahhas, A.¹, Towey, D.¹, Tait, P.¹, Ariff, B.¹, Wasan, H.², Hatice, G.², Habib, N.³, Barwick, T.¹

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. Sep2012, Vol. 39 Issue 9, p1391-1399. 9p. 2 Color Photographs, 5 Charts, 1 Graph.

Interobserver Agreement in Ultrasound Risk Stratification Systems for Thyroid Nodules on Static Images Versus Cine-Loop Video Sequences.

Autor: Schenke, Simone Agnes^1,2 (AUTHOR) simoneschenke@web.de, Petersen, Manuela³ (AUTHOR) manuela.petersen@med.ovgu.de, Görges, Rainer^4,5 (AUTHOR), Ruhlmann, Verena⁶ (AUTHOR), Zimny, Michael⁷ (AUTHOR), Richter, Johannes-Paul⁸ (AUTHOR), Groener, Daniel⁹ (AUTHOR), Baumgarten, Justus⁹ (AUTHOR), Kreissl, Michael C.^1,10 (AUTHOR), Stahl, Alexander R.¹¹ (AUTHOR), Grunert, Michael^12,13 (AUTHOR), Klemenz, Burkhard¹² (AUTHOR), Veit, Franziska¹⁴ (AUTHOR), Zettinig, Georg¹⁵ (AUTHOR), Seifert, Philipp¹⁶ (AUTHOR)

Publikováno v: Diagnostics (2075-4418). Oct2024, Vol. 14 Issue 19, p2138. 13p.

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial.

Autor: Kühnl A; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK.; Department of Haematology, King's College Hospital NHS Foundation Trust, London, UK., Peckitt C; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Patel B; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Ardeshna KM; University College London Hospital, London, UK., Macheta MP; Blackpool Victoria Hospital, Blackpool, UK., Radford J; University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Johnson R; St James's Hospital, Leeds, UK., Paneesha S; Heart of England NHS Foundation Trust, Birmingham, UK., Barton S; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK.; Wellington Blood and Cancer Centre, Wellington, New Zealand., Chau I; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Begum R; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, Surrey, UK., Wotherspoon A; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Du Y; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Zerizer I; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK., Cunningham D; Royal Marsden NHS Foundation Trust London and Surrey, Downs Road Sutton, Surrey, SM2 5PT, UK. david.cunningham@rmh.nhs.uk.

Publikováno v: Annals of hematology [Ann Hematol] 2020 Jan; Vol. 99 (1), pp. 105-112. Date of Electronic Publication: 2019 Nov 27.

Improving liver lesion characterisation using retrospective fusion of FDG PET/CT and MRI.

Autor: Parsai A; Barts Health NHS Trust, United Kingdom of Great Britain and Northern Ireland; Queen Mary University London, United Kingdom of Great Britain and Northern Ireland. Electronic address: Arman.Parsai@BartsHealth.nhs.uk., Miquel ME; Barts Health NHS Trust, United Kingdom of Great Britain and Northern Ireland; Queen Mary University London, United Kingdom of Great Britain and Northern Ireland., Jan H; Barts Health NHS Trust, United Kingdom of Great Britain and Northern Ireland., Kastler A; University Joseph Fourier, Grenoble, France., Szyszko T; King's College London, United Kingdom of Great Britain and Northern Ireland., Zerizer I; Royal Marsden Hospital, United Kingdom of Great Britain and Northern Ireland.

Publikováno v: Clinical imaging [Clin Imaging] 2019 May - Jun; Vol. 55, pp. 23-28. Date of Electronic Publication: 2019 Jan 23.